logo

For the Inventor, By the Inventor

Durham, NC, United States of America

Timothy A Jamieson

This inventor holds 1 USPTO granted patent. Top assignee: Duke University. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy A Jamieson. Retrieved from https://idiyas.com/inventor/timothy-a-jamieson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 2,078 
 
Duke University
 patents

Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents
1. 6218127 - Cancer prognosis with the M6P/IGF-II receptor (2001-04-17),

Title: The Innovative Contributions of Timothy A. Jamieson

Introduction

Timothy A. Jamieson is a notable inventor based in Durham, NC, who has made significant contributions to the field of cancer prognosis. His work focuses on the M6P/IGF-II receptor, which plays a crucial role in assessing cancer prognosis. With a keen interest in advancing medical science, Jamieson has developed innovative methods that can potentially improve patient outcomes.

Latest Patents

Jamieson holds a patent titled "Cancer prognosis with the M6P/IGF-II receptor." This invention relates to a method of assessing the prognosis of a patient using the M6P/IGF-II receptor. The patent highlights the importance of this receptor in understanding cancer progression and prognosis, showcasing Jamieson's commitment to enhancing cancer treatment methodologies. He has 1 patent to his name.

Career Highlights

Timothy A. Jamieson is affiliated with Duke University, where he contributes to research and innovation in the medical field. His role at the university allows him to collaborate with other experts and engage in groundbreaking research that has the potential to impact cancer prognosis significantly.

Collaborations

Jamieson has worked alongside esteemed colleagues such as Randy L. Jirtle and J. Keith Killian. These collaborations have fostered an environment of innovation and have led to advancements in cancer research and prognosis.

Conclusion

Timothy A. Jamieson's work exemplifies the intersection of innovation and medical science. His contributions to cancer prognosis through the M6P/IGF-II receptor are paving the way for improved patient care and outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…